Institutional Ownership
Contineum Therapeutics Inc
CUSIP 21217B100CL ACTNMQ1 2026
13D / 13G Filings
16
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
10.7%
Max % of class reported
Institutional Holders
86
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
16 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Ra Capital Management, L.P. | 13G/A | 7.2% | 2.18M | SEC |
| 2 | Feb 17, 2026 | Janus Henderson Group PLC | 13G | 7.9% | 2.45M | SEC |
| 3 | Feb 17, 2026 | Balyasny Asset Management L.P. | 13G | 7.6% | 2.31M | SEC |
| 4 | Jan 29, 2026 | Franklin Resources, Inc. | 13G/A | 6.2% | 1.88M | SEC |
| 5 | Nov 4, 2025 | Franklin Resources, Inc. | 13G/A | 7.7% | 1.66M | SEC |
| 6 | Aug 14, 2025 | Perceptive Advisors LLC | 13G/A | 3.2% | 699.5K | SEC |
| 7 | Aug 5, 2025 | Franklin Resources, Inc. | 13G/A | 8.9% | 1.70M | SEC |
| 8 | Jul 25, 2025 | Ra Capital Management, L.P. | 13G | 9.9% | 2.12M | SEC |
| 9 | May 15, 2025 | Perceptive Advisors LLC | 13G/A | 7.5% | 1.44M | SEC |
| 10 | Feb 14, 2025 | Sectoral Asset Management Inc | 13G/A | 5.0% | 950.8K | SEC |
6 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Contineum Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 2.84M | $37.11M |
| 2 | Janus Henderson Group PLC | 2.73M | $35.59M |
| 3 | Johnson & Johnson | 1.98M | $25.85M |
| 4 | Franklin Resources Inc | 1.84M | $24.02M |
| 5 | Balyasny Asset Management L.P. | 1.69M | $22.01M |
| 6 | Millennium Management LLC | 1.54M | $20.05M |
| 7 | Baker Bros. Advisors LP | 1.42M | $18.56M |
| 8 | Ra Capital Management, L.P. | 1.30M | $16.93M |
| 9 | Perceptive Advisors LLC | 1.26M | $16.40M |
| 10 | Fmr LLC | 814.9K | $10.64M |